The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense- The Case of the Insulin Glargine in Italy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.499
https://www.valueinhealthjournal.com/article/S1098-3015(17)30833-1/fulltext
Title :
The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense- The Case of the Insulin Glargine in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30833-1&doi=10.1016/j.jval.2017.08.499
First page :
A487
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
474